MP79-06 COMPARATIVE EFFICACY OF ENZALUTAMIDE, APALUTAMIDE AND DAROLUTAMIDE FOR TREATMENT ON NON-METASTATIC CASTRATE-RESISTANT PROSTATE CANCER: A NETWORK META-ANALYSIS | Zendy

AI Assistant Blog Pricing

MP79-06 COMPARATIVE EFFICACY OF ENZALUTAMIDE, APALUTAMIDE AND DAROLUTAMIDE FOR TREATMENT ON NON-METASTATIC CASTRATE-RESISTANT PROSTATE CANCER: A NETWORK META-ANALYSIS

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.